Clinical signs for differential diagnosis of eyelid tumours

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F23%3AE0110288" target="_blank" >RIV/00843989:_____/23:E0110288 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61988987:17110/23:A2402NHP

Výsledek na webu

<a href="https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1996-0950.pdf" target="_blank" >https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1996-0950.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1055/a-1996-0950" target="_blank" >10.1055/a-1996-0950</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Clinical signs for differential diagnosis of eyelid tumours

Popis výsledku v původním jazyce

This article aims to present the differential diagnostics of benign and malignant eyelid tumours. The most common malignant eyelid tumour is basal cell carcinoma, followed by squamous cell carcinoma. The common signs of malignity are loss of lashes, ulceration, and infiltration of the lesion. Often the clinical appearance is various and therefore only a histological analysis gives the proper diagnosis. For most tumours, surgical resection is the gold standard of therapy. The reconstruction of the defects should be performed by an experienced oculoplastic surgeon. In malignant tumours that require large safety margins, the defect can be easily very large, and the reconstruction must then be performed with advanced ophthalmic plastic reconstruction techniques.

Název v anglickém jazyce

Clinical signs for differential diagnosis of eyelid tumours

Popis výsledku anglicky

This article aims to present the differential diagnostics of benign and malignant eyelid tumours. The most common malignant eyelid tumour is basal cell carcinoma, followed by squamous cell carcinoma. The common signs of malignity are loss of lashes, ulceration, and infiltration of the lesion. Often the clinical appearance is various and therefore only a histological analysis gives the proper diagnosis. For most tumours, surgical resection is the gold standard of therapy. The reconstruction of the defects should be performed by an experienced oculoplastic surgeon. In malignant tumours that require large safety margins, the defect can be easily very large, and the reconstruction must then be performed with advanced ophthalmic plastic reconstruction techniques.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30207 - Ophthalmology

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Klinische Monatsblätter für Augenheilkunde

ISSN

0023-2165

e-ISSN

1439-3999

Svazek periodika

240

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

11

Strana od-do

13-23

Kód UT WoS článku

000950750800005

EID výsledku v databázi Scopus

2-s2.0-85147088583